China National Pharmaceutical Group Co Ltd (Sinopharm) has enterprises such as China National Pharmaceutical Investment Co Ltd, one of its wholly-owned subsidiaries, dedicated to high-end manufacturing and emerging services in the pharmaceutical and health sectors. They have invested in more than 20 leading companies in various sub-industries, spanning 17 specific areas, including anti-tumor, biochemical diagnostics, pathological diagnostics, pharmaceutical research and development and medicine packaging. 

Sinopharm has incubated numerous national level “little giants” and high-tech enterprises, fostering synergy and resource sharing between industrial investment and business sectors. 

Sinopharm Group Finance Co Ltd has actively leveraged its function as a financial platform, expanded its service capabilities, integrated into Sinopharm's treasury system and established a financial service development platform with distinctive Sinopharm characteristics.